Balaji Amines Limited

Balaji Amines Limited

Balaji Amines Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026, confirming the dematerialization of securities and update of depository records.

Balaji Amines Limited

Balaji Amines Limited has received a Warning cum Advisory Letter from SEBI for non-submission of disclosure under Regulation 30(2) read with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There is no material impact on financials, operations, or other activities of the Company.

Balaji Amines Limited

Balaji Amines Limited has received a warning letter from the Food & Drug Administration for selling a consignment of Propylene Glycol to a customer who used it for pharmaceutical purposes without the company's knowledge or consent, contravening the Drugs and Cosmetics Act, 1940. The company has reviewed its sales and documentation practices to prevent recurrence.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about Disclosure under Regulation 30(2) read with Regulation 30(6) of, and sub-para 20 of Para A of Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 regarding a license denial by the Office of the Joint Director General of Foreign Trade, Pune.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about the completion of tenure of Mr. Rajendrakumar Mohanprasad Tapadiya, Independent Director of Balaji Speciality Chemicals Limited, a Material Subsidiary of the Company.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, effective from 1st October, 2026, till the completion of 48 hours after the declaration of the Un-audited Financial Results for the Quarter and Half Year ended 30th September, 2026.

Balaji Amines Limited

Balaji Amines Limited has commenced commercial production of its Acetonitrile (ACN) Plant with enhanced capacity and improved process, effective from 24th September, 2026.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about the withdrawal of its credit rating by India Ratings and Research due to non-submission of due certificates from banks.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about the withdrawal of credit rating assigned to the company's bank loan facilities by India Ratings and Research (Ind-Ra) due to the company's no outstanding exposure to any bank.

Balaji Amines Limited

Balaji Amines Limited has published a newspaper advertisement regarding a special window for transfer and dematerialization of physical shares, as per SEBI Listing Regulations.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about a scheduled plant visit and management meet with investors and analysts on August 25th in Solapur, Maharashtra. The meet will be based on publicly available information and no unpublished price sensitive information will be disclosed.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about a scheduled Analysts/ Investors meet under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about Investor Presentation on Q1 FY27 Financial Results, with the presentation highlighting a strong operational and financial performance, resilient margins, and improving demand across key end-user industries.

Balaji Amines Limited

Balaji Amines Limited has published the extract of its standalone and consolidated un-audited financial results for the quarter ended 30th June, 2026, in Business Standard and Divya Marathi newspapers, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Balaji Amines Limited

Balaji Amines Limited has announced its unaudited financial results for the quarter ended June 30th, 2026, with revenue standing at ₹ 461 crore, EBITDA at ₹ 121 crore, and net profit at ₹ 78 crore. The company has also commissioned its 100,000 TPA Dimethyl Ether (DME) plant, marking a significant milestone in its strategic vision to diversify into new-age chemicals and alternate fuel applications.

Balaji Amines Limited

Balaji Amines Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 42,273.75 lakhs and profit for the period at Rs. 7,214.24 lakhs.

Balaji Amines Limited

Balaji Amines Limited has held its 38th Annual General Meeting (AGM) on July 10, 2026, through video conferencing. The meeting passed all resolutions with the required majority, including the adoption of audited financial statements, declaration of a dividend of Rs. 11 per equity share, and reappointment of a director. The company has also ratified the remuneration to cost auditors for the financial year 2026-27.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange regarding Proceedings of the 38th Annual General Meeting of the Company, where the resolutions proposed were adopted, including the declaration of a dividend of Rs. 11 per Equity Share for the Financial Year 2025-26.

Balaji Amines Limited

Balaji Amines Limited has informed the Exchange about Certificate under Regulations 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for Quarter Ended 30th June, 2026.

Balaji Amines Limited

Balaji Amines Limited has published a newspaper advertisement regarding their 2nd 100 days Saksham Niveshak Campaign and a special window for transfer and dematerialisation of physical shares.